X hits on this document

71 views

0 shares

0 downloads

0 comments

8 / 27

BreastCAP Approved

___ pN1c:Metastasis in 1 to 3 axillary lymph nodes and in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent

___ pN2a:Metastasis in 4 to 9 axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm)

___ pN2b:Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastases

___ pN3a:Metastasis in 10 or more axillary lymph nodes (at least 1 tumor deposit greater than 2.0 mm), or metastasis to the infraclavicular lymph nodes

___ pN3b:Metastasis in clinically apparent ipsilateral internal mammary lymph nodes in the presence of 1 or more positive axillary lymph nodes; or in more than 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent

___ pN3c:Metastasis in ipsilateral supraclavicular lymph nodes

Specify:Number examined: ____

Number involved: ____

Distant Metastasis (pM)

___ pMX:Cannot be assessed

___ pM1:Distant metastasis

*Specify site(s), if known: __________________________

Margins (check all that apply)

___ Margins cannot be assessed

___ Margins uninvolved by invasive carcinoma

Distance from closest margin: ___ mm

*Specify which margin: ____________________________

___ Margins uninvolved by DCIS (if present)

Distance from closest margin: ___ mm

*Specify which margin: ____________________________

___ Margin(s) involved by invasive carcinoma

Specify which margin: _____________________________

___ Margin(s) involved by DCIS

Specify which margin: _____________________________

*Extent of Margin Involvement for Invasive Carcinoma

*___ Cannot be assessed

*___ Unifocal

*___ Multifocal

*___ Extensive

*___ Other (specify): ____________________________

*Extent of Margin Involvement for DCIS

*___ Cannot be assessed

*___ Unifocal

*___ Multifocal

*___ Extensive

*  Data elements with asterisks are not required for accreditation purposes for the Commission on Cancer. These elements may be clinically important, but are not yet validated or regularly used in patient management. Alternatively, the necessary data may not be available to the pathologist at the time of pathologic assessment of this specimen.

Document info
Document views71
Page views71
Page last viewedSat Dec 10 05:50:13 UTC 2016
Pages27
Paragraphs698
Words8500

Comments